Immune control and failure in HCV infection--tipping the balance.
Despite the development of potent antiviral drugs, HCV remains a global health problem; global eradication is a long way off. In this review, we discuss the immune response to HCV infection and particularly, the interplay between viral strategies that delay the onset of antiviral responses and host...
Main Authors: | Dustin, L, Cashman, S, Laidlaw, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Federation of American Societies for Experimental Biology
2014
|
Similar Items
-
An HCV vaccine on the fly
by: Laidlaw, S, et al.
Published: (2019) -
The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.
by: Cashman, S, et al.
Published: (2014) -
Interferon lambda: opportunities, risks, and uncertainties in the fight against HCV
by: Laidlaw, S, et al.
Published: (2014) -
Innate and adaptive immune responses in chronic HCV infection
by: Dustin, L
Published: (2015) -
The humoral immune response to HCV: understanding is key to vaccine development
by: Siobhán B Cashman, et al.
Published: (2014-11-01)